Shree Hari Chemicals Export Ltd

Shree Hari Chemicals Export Limited announced that its board of directors re-appointed Bankesh Chandra Agrawal as Chairman & Managing Director for three years effective November 11, 2026, and re-appointed Sarthak Agarwal and Nihit Agarwal as Whole Time Directors for the same period, all subject to shareholder approval. Additionally, the board re-appointed Shri Ram Gupta as an Independent Director for a second five-year term effective September 29, 2026, and appointed Amrut Urkude as an Additional Independent Director for five years effective August 25, 2026, also pending shareholder approval.

Shree Hari Chemicals Export Limited informed the BSE that its board of directors approved an alteration of the company’s Memorandum of Association, adding sub-clauses related to dealing in cranes, lifting equipment, and material handling equipment, as well as investment in securities and infrastructure projects, subject to shareholder approval.

Shree Hari Chemicals Export Limited announced that its board approved the preferential allotment of 22,85,000 convertible warrants at a price of Rs 176.10 each, totaling Rs 40.24 crore, to promoters Nihit Agarwal, Priyamvada Agarwal, Avanticka Agarwal, and Smradhi Agarwal. The warrants, convertible into an equal number of equity shares, will be converted in tranches within 18 months, with 25% of the issue price paid at the time of subscription and the remaining 75% payable upon conversion.

Shree Hari Chemicals Export Limited will convene a board meeting on Tuesday, August 25, 2026, to consider and approve the issue of warrants on a preferential basis and to discuss the convening of the company’s 39th Annual General Meeting for approval of fund raising through warrants. Trading window for the company’s securities will be closed for directors, officers, designated employees, related parties, and other designated persons from Wednesday, August 19, 2026, until Thursday, August 27, 2026.

Shree Hari Chemicals Export Limited will convene a board meeting on Tuesday, August 25, 2026, to consider and approve the issue of warrants on a preferential basis and to discuss the convening of the company’s 39th Annual General Meeting for approval of fund raising through warrants. Trading window for the company’s securities will be closed for directors, officers, designated employees, related parties, and other designated persons from Wednesday, August 19, 2026, until Thursday, August 27, 2026.

Shree Hari Chemicals Export Ltd share price inched up 2.52% to Rs 182.85 after the company's net profit soared by 469.23% to Rs 5.92 crore, while revenue from operations gained significantly 33.21% to Rs 54.91 crore in Q2FY26 over Q1FY26. The market capitalization of Commodity Chemicals industry group stocks on BSE stood at Rs 1.63 lakh crore, climbing 10%. It has eased by 0.24% over last one week and moved up slightly by 1.05% in last one month while the market capitalization of Shree Hari Chemicals Export Ltd has marginally improved by 5.63% and 58.73% in the same period respectively. Profit before tax (PBT) of Shree Hari Chemicals Export Ltd stood at Rs 7.95 crore in Q2 FY26, nosediving by 458.11% year-on-year, and rallying 521.09% quarter-on-quarter. EBITDA came in at Rs 8 crore, crashing by 607.19% YoY and plunging by 579.01% sequentially. Total expenses went up by 13.70% to Rs 47.14 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 32.87 crore, surging by 30.80% YoY, while employee benefits expense was at Rs 4.48 crore, declining 8.94% YoY. For the TTM ended FY26, revenue from operations grew marginally by 2.07% to Rs 141.2 crore, while net profit jumped 122.71% to Rs 5.1 crore, compared to previous TTM. EBITDA saw a sharp decline of 168% to Rs 9.71 crore, and PBT witnessed a strong rise of 115.22% to Rs 6.93 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 0.8 crore in FY26, as against Rs 9.96 crore in FY25. Shree Hari Chemicals Export Ltd surged by 57.09% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 3.05% during the same period.

Shree Hari Chemicals Export Limited reported no deviations or variations in the utilization of proceeds from its preferential issue during the quarter ended June 30, 2026, according to a filing with the BSE Limited. The company, whose funds were raised on November 12, 2024, November 13, 2024, March 05, 2025, July 10, 2025 & July 11, 2025, for a total of Rs 14,74,59,820, confirmed that the proceeds have been fully utilized and align with the objects stated in the explanatory statement to the notice for the Annual General Meeting held on September 27, 2024.

Shree Hari Chemicals Export Limited will convene a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The trading window for the company's securities will reopen on Monday, August 17, 2026, following a 48-hour period after the financial results are declared.

Net profit of Shree Hari Chemicals Export rose 5100.00% to Rs 1.04 crore in the quarter ended March 2026 as against Rs 0.02 crore during the previous quarter ended March 2025. Sales rose 17.67% to Rs 41.22 crore in the quarter ended March 2026 as against Rs 35.03 crore during the previous quarter ended March 2025. For the full year,net profit declined 19.22% to Rs 4.12 crore in the year ended March 2026 as against Rs 5.10 crore during the previous year ended March 2025. Sales rose 30.67% to Rs 184.50 crore in the year ended March 2026 as against Rs 141.20 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales41.2235.03 18 184.50141.20 31 OPM %1.073.00 -3.567.49 - PBDT1.980.67 196 7.559.08 -17 PBT1.280.06 2033 5.196.93 -25 NP1.040.02 5100 4.125.10 -19 Powered by Capital Market - Live

Shree Hari Chemicals Export will hold a meeting of the Board of Directors of the Company on 15 May 2026.